Welltower stock trades close to record level as FY 2026 guidance and EPS outlook support valuation
Published on 08/27/2026 at 15:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Welltower Inc. (US95040Q1040) stock was quoted at $241.81 on August 27, 2026, keeping the health care real estate investment trust near the upper end of its recent trading range. Per recent market data, the shares trade against a fiscal 2026 earnings per share guidance band of 6.360 to 6.440 dollars, giving investors a clear numerical framework for the current valuation.
Guidance frames FY 2026 earnings path
Recent coverage highlights that Welltower has set its FY 2026 earnings per share guidance between 6.360 and 6.440 dollars, underlining management's confidence in the portfolio's cash flow potential for the current fiscal year. One detailed overview notes that sell-side analysts expect earnings per share of 6.44 dollars for FY 2026, essentially at the top of the company guidance range, which signals that the market is already pricing in execution close to the high end.
In the latest quarter discussed in this coverage, Welltower reported a quarterly earnings per share figure of 0.61 dollars, which serves as a reference point for the ramp needed to reach the full-year band. An earlier analysis pointed out that revenue in that quarter grew 39.1 percent compared with the same period a year earlier, illustrating the scale of the company's current growth phase even if that quarter now serves mainly as historical context in late August 2026.
Valuation close to consensus target
At a share price of $241.81 on August 27, 2026, Welltower's stock trades only a few dollars below a reported average analyst price target of $246.11. A consensus summary describes this 246.11 dollar level as the average target, and the small spread between the current price and that target implies a limited buffer on the upside if estimates do not move higher.
This relationship between price and target also provides a simple quantified comparison: the stock's $241.81 level stands less than 2 percent below the 246.11 dollar consensus, suggesting that much of the expected earnings progression to 6.44 dollars per share is already reflected in the valuation. For investors, this means that further price gains will likely depend on either guidance for FY 2026 moving above the current 6.360 to 6.440 range or on a continuation of high revenue growth after the recent quarter's 39.1 percent year-over-year increase.
Institutional interest and dividend context
Several recent filings describe new or increased institutional positions in Welltower, indicating continued interest from professional investors in the health care real estate story. One filing summary details a significant new stake measured in the tens or hundreds of millions of dollars, while other reports note additional purchases by various asset managers, underlining that the stock remains a core holding in many real estate and income-oriented portfolios.
Dividend information in the latest coverage points to a cash distribution of $0.85 per share paid to shareholders of record as of August 12 in the most recent cycle. One dividend-focused note mentions this 0.85 dollar payout, which, annualized, would imply $3.40 per share if maintained. Compared with the FY 2026 earnings guidance midpoint of 6.40 dollars per share, this suggests a payout ratio slightly above 50 percent, consistent with the cash distribution profile of a large health care real estate investment trust.
Portfolio exposure to health care real estate
Welltower's business model centers on acquiring and managing real estate serving the health care sector, including senior housing, medical office buildings, and post-acute care facilities. The company positions itself to benefit from demographic trends such as an aging population in North America and other key markets, which can drive demand for high-quality care infrastructure and long-term leases.
By focusing on long-term net leases and partnerships with health care operators, the company aims to convert these demographic trends into relatively stable rental cash flows that support its guidance range for FY 2026. This platform-centric approach, combining real estate expertise with operator relationships, helps explain how revenue in a recent quarter managed a 39.1 percent year-over-year increase, even if that figure now mainly serves as a historical benchmark for investors tracking the growth trajectory.
Current price level and recent range
Recent market commentary places Welltower's price at $241.81 on August 27, 2026, compared with a 12-month trading range that extends from $163.75 on the low side to $255.20 on the high side. One detailed price overview notes this range, which means the current level sits much closer to the upper end than to the bottom, reflecting the strong rerating that has occurred as earnings and guidance have improved.
Using these figures, investors can see that the stock's current price is around $78 above the 12-month low of $163.75 and only about $13 below the 12-month high of $255.20. This positioning underscores how expectations for FY 2026 earnings per share of 6.36 to 6.44 dollars and a consensus of 6.44 dollars have pushed the shares into territory that could be described as pricing in a significant portion of the anticipated growth.
Representative property segment spotlight
Within its portfolio, Welltower emphasizes senior housing operating and triple-net lease segments, which together drive a major share of rental and operating income. These properties range from independent living communities to assisted living and memory care facilities, often operated by specialized care providers under long-term agreements.
For investors, this segment is crucial because it translates demographic demand into occupancy and rate trends that support the FY 2026 earnings guidance. Strong performance in senior housing operating assets can contribute meaningfully to earnings per share, helping to bridge the gap between the latest quarterly EPS of 0.61 dollars and the full-year target band between 6.360 and 6.440 dollars.
Welltower stock price snapshot
As of August 27, 2026, recent market data shows Welltower stock trading at $241.81 on the New York Stock Exchange. This level compares with the 12-month high of $255.20 and the consensus target of $246.11, placing the shares in a zone where valuation depends heavily on management delivering on the FY 2026 guidance range of 6.360 to 6.440 dollars per share.
Fact box
Company: Welltower Inc.
ISIN: US95040Q1040
Ticker: WELL
Exchange: New York Stock Exchange
Price (as of August 27, 2026): $241.81 USD
Market cap: $173.94 billion (as of August 26, 2026)
Sector / Industry: Real estate investment trust, health care focused
Index membership: S&P 500
